2012•Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Requires access

Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test

P. Gómez-Camarero, A. Ortiz-de Tena, Isabel Borrego-Dorado, Ricardo Vazquez-Albertino, Elena Navarro-González, J.V. Ruiz-Franco-Baux, J.I. Cuenca-Cuenca

Open publisher page 12 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 12 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Medullary thyroid cancer, Calcitonin, Occult, Radiology, Thyroid cancer, Thyroid, Retrospective cohort study

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test — Research Paper | ScholarLens